Simon Allen Email and Phone Number
Simon Allen work email
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
Simon Allen personal email
- Valid
Simon Allen phone numbers
A biotech executive with a science background and 30+ years industry experience in leadership, strategy, business development, operations, and finance. A track record of generating value by matching pharmaceutical and biotech partners with a variety of technologies and products.Completed partnerships include:Bristol-Myers Squibb, Astellas Pharma Inc., Merck & Co., Inc, Eli Lilly and Company, Bayer AG, Pfizer, Inc., GlaxoSmithKline, Amgen, Inc., Alcon Laboratories, Inc., Sino Biopharma, Zhejiang Medicine Co., BeiGene, Astellas, Avecia Biologics, Ltd., Kirin Co., Ltd, Chugai Pharmaceutical Co., Ltd., Kyowa Hakko Co., Ltd.
Eof Bio
View-
Eof BioRancho Santa Fe, Ca, Us
-
Chief Executive OfficerEof Bio Feb 2024 - PresentCommitted to Discovering, Developing and Commercializing CBD-based Therapeutics for Women’s Health
-
Senior Advisor And Sab MemberProto Axiom Dec 2023 - PresentNorth Sydney, New South Wales, AuAdvisory role to assist in the evaluation and management of direct investments within the biotechnology sector.
-
CeoAnebulo Pharmaceuticals Feb 2022 - Oct 2023Advanced a Phase 1 clinical stage biotech to Phase 3 ready in 21 months and $19M, well ahead of industry expectations.Optimized ANEB-001 by identifying and optimizing parenteral formulations and filing additional patents.Streamlined operations by establishing an integrated and outsourced business model for non-core activities such as finance, investor and public relations, legal, SEC, and GMP.Established analyst coverage with three leading investment banks.
-
CboAmbrx Mar 2019 - Jan 2022San Diego, Ca, UsOversaw global business development, corporate strategy, public relations, and operations. Worked closely with the CEO to shift strategy and prioritize pipeline. Restructuring led to a $200M crossover and a $142M IPO on the NYSE with blue chip investors. Significant support of financial, legal and IP activities.Established and managed multiple partnerships with leading pharmaceutical companies. -
CeoCohbar, Inc. Mar 2016 - Dec 2018Menlo Park, California, UsCohBar, Inc. is an innovative biotechnology company whose mission is to treat major diseases and extend healthy life spans through the discovery of novel Mitochondrial-Derived Peptides ("MDPs") and the advancement of their development into clinically relevant and commercially successful therapeutics. -
ConsultantSolstice Biologics Feb 2015 - Feb 2016* Supporting business development activities
-
Chief Business OfficerAmbrx Sep 2010 - Jan 2015San Diego, Ca, Us* Responsible for the company’s global business development strategy* Identified and completed multiple technology and product focused collaborations that realized over $120M in non-dilutive revenue to date with $1.5B in potential milestones plus royalties remaining* Helped establish a China strategy for drug development
-
CeoKalypsys Apr 2008 - Jun 2010* Set the strategy, vision and culture for a small molecule high throughput drug discovery organization* Restructured the company during the global financial crisis* Renegotiated commercial rights to collaboration compounds with Alcon
-
CcoCovx (Subsidiary Of Pfizer) Aug 2006 - Mar 2008Us* Responsible for business development and corporate initiatives* Established guidance on commercial and strategic rationale of the product pipeline* Ran an M&A process culminating with Pfizer acquiring CovX -
Vp Business DevelopmentNuvelo Jul 2004 - Feb 2006Us* Completed collaborations that generated $105M in non-dilutive revenue* Lead collaboration with Bayer resulted in a $350M increase in the company’s market cap that helped support a $119M secondary financing -
Vp Business DevelopmentSkyepharma Apr 2002 - Jul 2004Saint-Quentin-Fallavier, Auvergne-Rhône-Alpes, Fr* Part of a team that ran global BD and strategy for a drug delivery company* Completed several collaborations that matched drug delivery technologies to partners compounds* Divested the company’s dermatology division -
VariousAgy Therapeutics, Corixa, Bby, Robertson Stephens & Co, Gilead Sciences, Burns Philp 1990 - 2002Responsibilities included business development, equities analyst, investment banking, and pharmaceutical research and development
Simon Allen Skills
Simon Allen Education Details
-
Agsm @ Unsw Business SchoolFinance -
University Of SydneyBiochemistry And Genetics
Frequently Asked Questions about Simon Allen
What company does Simon Allen work for?
Simon Allen works for Eof Bio
What is Simon Allen's role at the current company?
Simon Allen's current role is C-level executive with 30+ years of global biotechnology experience spanning multiple technology platforms and therapeutic sectors..
What is Simon Allen's email address?
Simon Allen's email address is ku****@****hoo.com
What is Simon Allen's direct phone number?
Simon Allen's direct phone number is +141538*****
What schools did Simon Allen attend?
Simon Allen attended Agsm @ Unsw Business School, University Of Sydney.
What skills is Simon Allen known for?
Simon Allen has skills like Biotechnology, Business Development, Pharmaceutical Industry, Commercialization, Technology Transfer, Drug Development, Life Sciences, Corporate Development, Mergers And Acquisitions, Strategy, Strategic Partnerships, Drug Discovery.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial